ArticleNature cancer2026

Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance.

Hui Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.